本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

62.51
-3.2800-4.99%
盤前62.41-0.1003-0.16%07:02 EDT
成交量:209.78萬
成交額:1.31億
市值:58.92億
市盈率:-131.20
高:65.32
開:65.31
低:61.40
收:65.79
52周最高:68.73
52周最低:22.06
股本:9,426.11萬
流通股本:9,276.71萬
量比:1.68
換手率:2.26%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
淨資產收益率:-236.35%
總資產收益率:-3.73%
市淨率:240.28
市盈率(LYR):-218.30

資料載入中...

2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

重要事件披露

Form 8-K - Current report
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/07

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities